The China Honeymoon Is Over: Global Medtech Must Think Decisively

It Should Be No Surprise That The Challenge Of China Will Only Ratchet Up Further

19 Jul 2022

China is transitioning to an economy driven by innovation and technology, with differential effects on foreign medtechs depending on their place in the value chain and type of innovation. China commentators have been updating the market.

Market entry in China and the conditions for competing locally are becoming incrementally harder for foreign medtech innovators seeking to serve fast-growing patient demand in a population of 1.439 billion people (in 2020, sourced from OECD on 6 July 2022).

Foreign companies with mainstream medtech offerings can expect market access in China to become more and more difficult, according to...